Literature DB >> 34135335

Controlling the pandemic during the SARS-CoV-2 vaccination rollout.

João Viana1,2, Christiaan H van Dorp3, Ana Nunes2,4, Manuel C Gomes2, Michiel van Boven1, Mirjam E Kretzschmar1, Marc Veldhoen5, Ganna Rozhnova6,7.   

Abstract

There is a consensus that mass vaccination against SARS-CoV-2 will ultimately end the COVID-19 pandemic. However, it is not clear when and which control measures can be relaxed during the rollout of vaccination programmes. We investigate relaxation scenarios using an age-structured transmission model that has been fitted to age-specific seroprevalence data, hospital admissions, and projected vaccination coverage for Portugal. Our analyses suggest that the pressing need to restart socioeconomic activities could lead to new pandemic waves, and that substantial control efforts prove necessary throughout 2021. Using knowledge on control measures introduced in 2020, we anticipate that relaxing measures completely or to the extent as in autumn 2020 could launch a wave starting in April 2021. Additional waves could be prevented altogether if measures are relaxed as in summer 2020 or in a step-wise manner throughout 2021. We discuss at which point the control of COVID-19 would be achieved for each scenario.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34135335     DOI: 10.1038/s41467-021-23938-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  26 in total

1.  Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.

Authors:  Wadim Koslow; Martin J Kühn; Sebastian Binder; Margrit Klitz; Daniel Abele; Achim Basermann; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2022-05-16       Impact factor: 4.779

Review 2.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

3.  COVID-19 vaccination during pregnancy: coverage and safety.

Authors:  Helena Blakeway; Smriti Prasad; Erkan Kalafat; Paul T Heath; Shamez N Ladhani; Kirsty Le Doare; Laura A Magee; Pat O'Brien; Arezou Rezvani; Peter von Dadelszen; Asma Khalil
Journal:  Am J Obstet Gynecol       Date:  2021-08-10       Impact factor: 10.693

Review 4.  The benefits, costs and feasibility of a low incidence COVID-19 strategy.

Authors:  Thomas Czypionka; Emil N Iftekhar; Barbara Prainsack; Viola Priesemann; Simon Bauer; André Calero Valdez; Sarah Cuschieri; Enrico Glaab; Eva Grill; Jenny Krutzinna; Christos Lionis; Helena Machado; Carlos Martins; George N Pavlakis; Matjaž Perc; Elena Petelos; Martyn Pickersgill; Alexander Skupin; Eva Schernhammer; Ewa Szczurek; Sotirios Tsiodras; Peter Willeit; Paul Wilmes
Journal:  Lancet Reg Health Eur       Date:  2022-01-02

5.  Determinants of COVID-19 Vaccine Acceptance among the Adult Population of Bangladesh Using the Health Belief Model and the Theory of Planned Behavior Model.

Authors:  Muhammad Mainuddin Patwary; Mondira Bardhan; Asma Safia Disha; Mehedi Hasan; Md Zahidul Haque; Rabeya Sultana; Md Riad Hossain; Matthew H E M Browning; Md Ashraful Alam; Malik Sallam
Journal:  Vaccines (Basel)       Date:  2021-11-25

6.  Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.

Authors:  Paolo Bosetti; Cécile Tran Kiem; Alessio Andronico; Vittoria Colizza; Yazdan Yazdanpanah; Arnaud Fontanet; Daniel Benamouzig; Simon Cauchemez
Journal:  BMC Med       Date:  2022-01-26       Impact factor: 8.775

7.  Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.

Authors:  Debra Van Egeren; Madison Stoddard; Alexander Novokhodko; Michael S Rogers; Diane Joseph-McCarthy; Bruce Zetter; Arijit Chakravarty
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

8.  Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.

Authors:  Ugo Avila-Ponce de León; Eric Avila-Vales; Kuanlin Huang
Journal:  Viruses       Date:  2022-01-16       Impact factor: 5.048

9.  Immunity in the ABM-DSGE Framework for Preventing and Controlling Epidemics-Validation of Results.

Authors:  Jagoda Kaszowska-Mojsa; Przemysław Włodarczyk; Agata Szymańska
Journal:  Entropy (Basel)       Date:  2022-01-14       Impact factor: 2.524

10.  Cyberchondria, Fear of COVID-19, and Risk Perception Mediate the Association between Problematic Social Media Use and Intention to Get a COVID-19 Vaccine.

Authors:  Daniel Kwasi Ahorsu; Chung-Ying Lin; Zainab Alimoradi; Mark D Griffiths; Hsin-Pao Chen; Anders Broström; Toomas Timpka; Amir H Pakpour
Journal:  Vaccines (Basel)       Date:  2022-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.